Related Experiment Video
Updated: Apr 21, 2026
07:51
Refined Murine Model of Idiopathic Pulmonary Fibrosis
Published on: June 17, 2025
1.3K
Summary
Fibroblasts drive fibrosis. Modulating their phenotype offers therapeutic targets to halt fibrogenesis, the process of scar tissue formation in organs.
Area of Science:
- Cell Biology
- Pathology
- Pharmacology
Context:
- Fibroblasts are central to fibrotic diseases.
- Their behavior is shaped by the extracellular matrix and signaling molecules.
- Understanding these interactions is crucial for developing treatments.
Purpose:
- To explore the role of fibroblast phenotype in fibrosis.
- To investigate pharmacologic strategies for modulating fibroblast behavior.
- To identify potential therapeutic targets for fibrotic conditions.
Summary:
- Fibroblasts adopt a profibrotic phenotype influenced by their microenvironment.
- Pharmacologic interventions can alter this fibroblast phenotype.
- This modulation highlights potential strategies to interrupt pulmonary fibrogenesis.
Impact:
- Identifies fibroblast phenotype modulation as a therapeutic avenue.
- Suggests new targets for treating fibrotic lung diseases.
- Provides insights into the mechanisms of fibrogenesis.
Related Concept Videos
01:09Introduction to Fibroblasts
3.9K
Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
3.9K
01:24Cirrhosis II: Pathophysiology
24
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
24
01:12Chronic Inflammation: Introduction
7
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
7
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.9K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.9K
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
16
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
16
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
23
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
23